246 Views | 140 Downloads
Rohan H. C. Palmer, Ph. D., Behavior Genetics of Addiction Laboratory, Department of Psychology at Emory University, 36 Eagle Row, Room 379, Atlanta, GA 30322, rohan.palmer@emory.edu
Drs. Palmer and Keller designed the current project.
Drs. Palmer and Brick conducted the analyses under the supervision of Dr. Keller.
Drs. Palmer and Brick conducted literature searches and co-wrote the first draft of the manuscript, which was later reviewed and edited by Drs. Keller, Knopik and McGeary.
All authors contributed to and have approved the final manuscript.
The authors gratefully acknowledge Mr. Bryce Christensen and Golden Helix (Bozeman, Montana) for their assistance with data preparation for genomic imputation analyses.
Further, we acknowledge the services of the Michigan Imputation Server team for the use of their publicly available resource for genomic imputation.
Lastly, we acknowledge the many grant funded research projects (described below) that assembled all of the data used in the current study, as well as the NIH’s database for Genotypes and Phenotypes, which provides a platform for data sharing.
Funding support for the SAGE study was supported by NIH and NHLBI grant # R01HL117004; study enrollment supported by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II.
Funding support for the OZ-ALC GWAS was provided through the Center for Inherited Disease Research (CIDR) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
CIDR-OZ-ALC GWAS was funded as part of the NIAAA grant 5 R01 AA013320–04. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the CIDROZ-ALC GWAS.
Assistance with data cleaning was provided by the National Center for Biotechnology Information.
Support for collection of OZ-ALC datawas provided by the MARC: Risk Mechanisms in Alcoholism and Comorbidity (MARC; P60 AA011998–11).
Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, and the NIH contract “High throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C).
Funding support for the Yale Study was provided through the Center for Inherited Disease Research (CIDR) and the Genetics of Alcohol Dependence in American Populations (CIDR-Gelernter Study). CIDR-Gelernter Study is a genome-wide association studies funded as part of the Genetics of Alcohol Dependence in American Populations. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the Genetics of Alcohol Dependence in American Populations.
Finally, funding support for the GWAS of Heroin Dependence was provided by R01DA17305.
This project was supported by a K01 grant (K01AA021113 awarded to Dr. Palmer) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a T32 (T32MH019927; which supports the postdoctoral training of Dr. Brick), and an R01 (MH100141) from the National Institute on Mental Health (NIMH; awarded to Dr. Keller).
© 2017 Society for the Study of Addiction